Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ischemic Heart Disease

  Free Subscription


26.05.2025

1 AJR Am J Roentgenol
3 Am Heart J
2 Am J Cardiol
3 Am J Med
2 Angiology
2 Ann Intern Med
1 Arterioscler Thromb Vasc Biol
3 BMJ
1 Circ Cardiovasc Imaging
5 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
1 Circ Heart Fail
4 Circ Res
2 Circulation
2 Eur Heart J
1 Heart
2 Int J Cardiol
1 J Am Coll Cardiol
2 J Clin Endocrinol Metab
1 JAMA
1 Mol Cell Biochem
2 N Engl J Med
1 PLoS Med
6 PLoS One
2 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CHELALA L
    Refining Coronary Artery Disease Screening: Is Coronary Calcium Scoring Enough?
    AJR Am J Roentgenol. 2025 May 21. doi: 10.2214/AJR.25.33228.
    PubMed        


    Am Heart J

  2. GOLD ME, Kulkarni S, Yadalam A, Patel KJ, et al
    Cardiac Allograft Vasculopathy Mediates the Relationship Between Vitamin D Deficiency and Cardiovascular Mortality Following Heart Transplantation.
    Am Heart J. 2025 May 16:S0002-8703(25)00166-8. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available

  3. WHITE HD, O'Brien SM, Boden WE, Fremes SE, et al
    Use of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention and Associated Outcomes in the ISCHEMIA Trial.
    Am Heart J. 2025 May 20:S0002-8703(25)00165-6. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available

  4. RAI B, Yildiz M, Bergstedt S, Bandari A, et al
    Diversity of Electrocardiographic Patterns in Left Main Culprit Acute ST-Elevation Myocardial Infarction.
    Am Heart J. 2025 May 14:S0002-8703(25)00164-4. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available


    Am J Cardiol

  5. NAVAR AM, Electricwala B, Multani JK, Zhou Z, et al
    Erratum to 'Lipid Management in United States Commercial and Medicare Enrollees With Atherosclerotic Cardiovascular Disease: Treatment Patterns and Low-Density Lipoprotein Cholesterol Control' [The American Journal of Cardiology 242 (2025) 1-9].
    Am J Cardiol. 2025 May 17:S0002-9149(25)00305.
    PubMed        

  6. NDREPEPA G
    Minimally Invasive Direct Coronary Artery Bypass or Percutaneous Coronary Intervention With Drug-eluting stents for Isolated Left Anterior Descending Artery Stenosis: Brief Title: MIDCAB or DES for isolated LAD stenosis.
    Am J Cardiol. 2025 May 15:S0002-9149(25)00315.
    PubMed        


    Am J Med

  7. KU L, Yan Q, Deng W, Ma X, et al
    Right Coronary Artery Ulcerated Atheromatous Plaque.
    Am J Med. 2025 May 18:S0002-9343(25)00240-2. doi: 10.1016/j.amjmed.2025.
    PubMed        

  8. FROOM P, Lellouche J, Shimoni Z
    TROPONIN TESTS IN PATIENTS ADMITTED TO INTERNAL MEDICINE DEPARTMENTS WITHOUT AN ACUTE CORONARY SYNDROME- LESS IS MORE.
    Am J Med. 2025 May 20:S0002-9343(25)00305-5. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available

  9. OLA O, Knott JD, De Michieli L, Lobo R, et al
    Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T.
    Am J Med. 2025 May 18:S0002-9343(25)00304-3. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available


    Angiology

  10. AYDIN C, Demirkiran A, Orta H
    Risk Scores for Cardiovascular Events in NSTEMI Patients with Multi-vessel Disease.
    Angiology. 2025 May 22:33197251345864. doi: 10.1177/00033197251345864.
    PubMed        

  11. ENGIN M, Ari H, Aydin U, Ata Y, et al
    Effect of Admission Blood Glucose on Long-term Prognosis After Coronary Artery Bypass Grafting.
    Angiology. 2025 May 22:33197251345395. doi: 10.1177/00033197251345395.
    PubMed        


    Ann Intern Med

  12. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    PubMed         Abstract available

  13. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  14. RICCIOTTI E, FitzGerald GA
    Prostaglandins and the Cardiovascular System.
    Arterioscler Thromb Vasc Biol. 2025;45:841-844.
    PubMed        


    BMJ

  15. BORLAND S
    Why are UK cardiovascular deaths in under 65s rising again?
    BMJ. 2025;389:r1015.
    PubMed        


  16. Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2025;389:r863.
    PubMed        


  17. Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2025;389:r859.
    PubMed        


    Circ Cardiovasc Imaging

  18. LU G, Zhao L, Hui K, Lu Z, et al
    Angiography-Derived Microcirculatory Resistance in Detecting Microvascular Obstruction and Predicting Heart Failure After STEMI.
    Circ Cardiovasc Imaging. 2025 Apr 3:e017506. doi: 10.1161/CIRCIMAGING.124.017506
    PubMed         Abstract available


    Circ Cardiovasc Interv

  19. SCALA A, Erriquez A, Cocco M, Verardi FM, et al
    Coronary Atherosclerosis Phenotypes in Non-Flow-Limiting Nonculprit Lesions of Older Patients With MI Stratified by Focal and Diffuse Disease Patterns.
    Circ Cardiovasc Interv. 2025 May 20:e015281.
    PubMed        

  20. YAMAMOTO K, Shiomi H, Morimoto T, Miyazawa A, et al
    Correction to: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2025;18:e000097.
    PubMed        

  21. EZENNA C, Krishna MM, Joseph M, Ibrahim S, et al
    Optical Coherence Tomography vs. Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials.
    Circ Cardiovasc Interv. 2025 Mar 30. doi: 10.1161/CIRCINTERVENTIONS.125.015141.
    PubMed         Abstract available

  22. HAN JK, Lee K, Park SH, Yang S, et al
    Short-Term DAPT After Complex PCI With Third-Generation DES: A Post Hoc Analysis of the HOST-IDEA Trial.
    Circ Cardiovasc Interv. 2025 Mar 31:e014623.
    PubMed         Abstract available

  23. PLEVA L, Kukla P, Kovarnik T, Zapletalova J, et al
    Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study).
    Circ Cardiovasc Interv. 2025;18:e014677.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  24. DIAZ KM, Boudreaux BD, Xu C, Sanchez GJ, et al
    Sedentary Behavior and Cardiac Events and Mortality After Hospitalization for Acute Coronary Syndrome Symptoms: A Prospective Study.
    Circ Cardiovasc Qual Outcomes. 2025 May 19:e011644.
    PubMed         Abstract available


    Circ Heart Fail

  25. BLUMER V, Hanff TC, Gage A, Schrage B, et al
    Cardiogenic Shock Teams: Past, Present, and Future Directions.
    Circ Heart Fail. 2025;18:e011630.
    PubMed         Abstract available


    Circ Res

  26. LEE CJM, Kosyakovsky LB, Khan MS, Wu F, et al
    Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos.
    Circ Res. 2025;136:1170-1207.
    PubMed         Abstract available

  27. ZIEGLER KA, Engelhardt S, Carnevale D, McAlpine CS, et al
    Neural Mechanisms in Cardiovascular Health and Disease.
    Circ Res. 2025;136:1233-1261.
    PubMed         Abstract available

  28. MOHANTA SK, Heron C, Klaus-Bergmann A, Horstmann H, et al
    Metabolic and Immune Crosstalk in Cardiovascular Disease.
    Circ Res. 2025;136:1433-1453.
    PubMed         Abstract available

  29. JUGUILON C, Khosravi R, Radisic M, Wu JC, et al
    In Vitro Modeling of Interorgan Crosstalk: Multi-Organ-on-a-Chip for Studying Cardiovascular-Kidney-Metabolic Syndrome.
    Circ Res. 2025;136:1476-1493.
    PubMed         Abstract available


    Circulation

  30. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    PubMed        

  31. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    PubMed        


    Eur Heart J

  32. CLELAND JGF
    Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
    Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
    PubMed        

  33. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
    Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
    PubMed         Abstract available


    Heart

  34. FIOLET ATL, Lin A, Kwiecinski J, Tutein Nolthenius J, et al
    Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial.
    Heart. 2025 May 19:heartjnl-2024-325527. doi: 10.1136/heartjnl-2024-325527.
    PubMed         Abstract available


    Int J Cardiol

  35. HAIDER A, Imran A
    Comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
    Int J Cardiol. 2025;435:133394.
    PubMed        

  36. DZIEWIERZ A
    Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
    Int J Cardiol. 2025;435:133395.
    PubMed        


    J Am Coll Cardiol

  37. WITTELES RM, Garcia-Pavia P, Damy T, Grogan M, et al
    Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B.
    J Am Coll Cardiol. 2025 Apr 30:S0735-1097(25)06170.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  38. LU X, Zhu X, Li G, Wu L, et al
    Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity.
    J Clin Endocrinol Metab. 2025;110:e1845-e1855.
    PubMed         Abstract available

  39. POHLMAN N, Patel PN, Essien UR, Tang JJ, et al
    Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era.
    J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210.
    PubMed         Abstract available


    JAMA

  40. KIM JH, Rim AJ, Miller JT, Jackson M, et al
    Cardiac Arrest During Long-Distance Running Races.
    JAMA. 2025;333:1699-1707.
    PubMed         Abstract available


    Mol Cell Biochem

  41. SAVIC M, Dragasevic N, Sretenovic J, Mihajlovic K, et al
    The impact of combination of zofenopril and different diuretics on regression of myocardial reperfusion injury and oxidative status in spontaneously hypertensive rats.
    Mol Cell Biochem. 2025;480:3695-3708.
    PubMed         Abstract available


    N Engl J Med

  42. QIU Z, Li F, Sang H, Yuan G, et al
    Intravenous Tenecteplase before Thrombectomy in Stroke.
    N Engl J Med. 2025 May 21. doi: 10.1056/NEJMoa2503867.
    PubMed         Abstract available

  43. KAWAI T, Williams WW, Elias N, Fishman JA, et al
    Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.
    N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2412747.
    PubMed         Abstract available


    PLoS Med

  44. NI W, Stafoggia M, Zhang S, Ljungman P, et al
    Short-term exposure to ambient temperature variability and myocardial infarction hospital admissions: A nationwide case-crossover study in Sweden.
    PLoS Med. 2025;22:e1004607.
    PubMed         Abstract available


    PLoS One

  45. SIAHAAN PP, Widiarti W, Saputra PBT, Putra RM, et al
    Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting in-stent restenosis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0322461.
    PubMed         Abstract available

  46. ALMOGHAIRI AM, O'Brien J, Doubrovsky A, Duff J, et al
    Knowledge, attitudes, and practices of cardiac rehabilitation and barriers to referral among cardiologists in Saudi Arabia: A cross-sectional survey.
    PLoS One. 2025;20:e0323694.
    PubMed         Abstract available

  47. YANG J, Liu J, Liu X, Xu D, et al
    Downregulation of OIP5-AS1 inhibits apoptosis in myocardial ischemia/reperfusion injury via modulating the MiR-145-5p/ROCK1 axis.
    PLoS One. 2025;20:e0324909.
    PubMed         Abstract available

  48. UL HAQ MS, Jawed DN, Patel N, Khan W, et al
    Exploring anxiety symptoms, coping strategies, and socio-demographic influences among myocardial infarction patients in a tertiary care setting.
    PLoS One. 2025;20:e0323904.
    PubMed         Abstract available

  49. WIECKIEL-LISOWSKA K, Wojciechowska A, Wierucki L, Woch S, et al
    Excess prevalence of chronic diseases in elderly people with diabetes and non-diabetics in Poland.
    PLoS One. 2025;20:e0319242.
    PubMed         Abstract available

  50. LEE SK, Xiong T, Qian AS, Yoo JA, et al
    Scavenger receptor class B type I knockout mice develop extensive diet-induced coronary artery atherosclerosis in an age-dependent manner.
    PLoS One. 2025;20:e0318118.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  51. KERMANSHAHCHI J, Kao AS, Ellberg CC, Duran E, et al
    First presentation of atherosclerotic cardiovascular disease in previously healthy individuals: The multi-ethnic study of atherosclerosis.
    Prog Cardiovasc Dis. 2025 May 14:S0033-0620(25)00075.
    PubMed         Abstract available

  52. KAZIBWE R, Jehopio J, Schaich CL, Rikhi R, et al
    Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension.
    Prog Cardiovasc Dis. 2025 May 18:S0033-0620(25)00069.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.